GHK-Cu and peptides for anti-aging skin: what TikTok skips

What's this video probably claiming?

Based on the caption framing, hashtags like firmskin and antiagingroutine, and the peptides category this video is tagged under, @its_mikki_bish is almost certainly walking viewers through a skincare regimen that includes copper peptides, specifically GHK-Cu, as a "non-negotiable" anti-aging ingredient for people over 35. The pitch pattern here is familiar: age-related collagen loss, the skin-transforming potential of peptide serums, and some version of the claim that topical peptides can meaningfully reverse or slow visible aging. There may also be mentions of growth hormone secretagogues like ipamorelin or CJC-1295 framed as systemic skin-health tools, which is a different and much murkier category. The "professional-level advice" framing in the caption is worth flagging immediately. Skincare content creators using that phrase typically have esthetician backgrounds at best, not clinical training, and the distinction matters when bioactive peptides enter the conversation.

What does the science actually show?

GHK-Cu (copper tripeptide-1) has legitimate research behind it, more than most ingredients in this space. Pickart and Margolina (2018, Biomolecules) documented its role in stimulating collagen and glycosaminoglycan synthesis and modulating matrix metalloproteinases. A double-blind study by Leyden et al. found measurable improvements in fine line depth and skin laxity with topical GHK-Cu application over 12 weeks, though effect sizes were modest. Concentration matters enormously here: most over-the-counter serums contain 1-2% copper peptide complexes, while studied formulations often used higher concentrations under controlled conditions. For systemic peptides like ipamorelin and CJC-1295, the skin benefit data is essentially nonexistent in peer-reviewed literature. These are growth hormone secretagogues studied in clinical contexts for GH deficiency and body composition, not dermatology. Any claim that injectable or oral secretagogues produce meaningful skin rejuvenation in healthy adults over 35 is extrapolation, not evidence.

Where does the social media noise diverge from clinical reality?

The gap is significant in a few specific ways. First, topical peptides face a basic delivery problem that skincare TikTok rarely acknowledges: peptide molecules are often too large to penetrate the stratum corneum effectively. GHK-Cu is relatively small and has better penetration data than most, but calling it equivalent to injected peptides or clinical-grade treatments is not supported. Second, the "over 35" framing implies a universal inflection point in skin biology, which is reductive. Collagen loss begins in the mid-20s at roughly 1% per year according to Varani et al. (2006, American Journal of Pathology), so the "suddenly your skin is different at 35" narrative is more marketing than physiology. Third, if this video touches on systemic peptides for skin health, viewers should know that MK-677 (ibutamoren), sometimes framed as an oral GH secretagogue, is not FDA-approved and carries real cardiovascular and insulin resistance risks documented in longer-term studies, including Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism).

What should you actually know?

GHK-Cu is one of the better-researched topical peptides and has a reasonable evidence base for modest improvements in skin texture and firmness when used consistently in adequate concentrations. It belongs in a conversation about evidence-based skincare. Retinoids and broad-spectrum SPF still have stronger long-term evidence than any peptide for anti-aging outcomes, and any regimen that doesn't start there is working backwards. Systemic peptides for cosmetic skin improvement in otherwise healthy adults are not supported by controlled clinical trials, and accessing them through unregulated channels carries risks that a TikTok skincare reel is not going to walk you through. If a creator is recommending injectable peptides as part of a "skin regimen" without a prescribing clinician in the loop, that is not professional-level advice. It is a liability. Consult a board-certified dermatologist or a licensed telehealth provider before adding any peptide, topical or systemic, to your routine based on social content.